6.
Mullerpattan J, Udwadia Z, Banka R, Ganatra S, Udwadia Z
. Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India. Indian J Tuberc. 2019; 66(1):87-91.
DOI: 10.1016/j.ijtb.2018.04.011.
View
7.
Chan P, Huang S, Yu M, Lee S, Huang Y, Chien S
. Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study. PLoS One. 2013; 8(2):e57719.
PMC: 3581541.
DOI: 10.1371/journal.pone.0057719.
View
8.
Govender T, Jham M, Zhang J, Pillay S, Pak Y, Pillay P
. Decentralized, Integrated Treatment of RR/MDR-TB and HIV Using a Bedaquiline-Based, Short-Course Regimen Is Effective and Associated With Improved HIV Disease Control. J Acquir Immune Defic Syndr. 2023; 92(5):385-392.
PMC: 10006315.
DOI: 10.1097/QAI.0000000000003150.
View
9.
McQuaid C, Henrion M, Burke R, MacPherson P, Nzawa-Soko R, Horton K
. Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries. BMC Med. 2022; 20(1):432.
PMC: 9660190.
DOI: 10.1186/s12916-022-02624-6.
View
10.
Manhica I, Augusto O, Sherr K, Cowan J, Cuco R, Agostinho S
. COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020. BMJ Glob Health. 2022; 7(4).
PMC: 9021460.
DOI: 10.1136/bmjgh-2021-007878.
View
11.
Williams V, Calnan M, Edem B, Onwuchekwa C, Okoro C, Candari C
. GeneXpert rollout in three high-burden tuberculosis countries in Africa: A review of pulmonary tuberculosis diagnosis and outcomes from 2001 to 2019. Afr J Lab Med. 2022; 11(1):1811.
PMC: 9453189.
DOI: 10.4102/ajlm.v11i1.1811.
View
12.
Odone A, Roberts B, Dara M, van den Boom M, Kluge H, McKee M
. People- and patient-centred care for tuberculosis: models of care for tuberculosis. Int J Tuberc Lung Dis. 2018; 22(2):133-138.
DOI: 10.5588/ijtld.17.0608.
View
13.
Leavitt S, Jacobson K, Ragan E, Bor J, Hughes J, Bouton T
. Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa. Emerg Infect Dis. 2021; 27(3):728-739.
PMC: 7920662.
DOI: 10.3201/eid2703.203204.
View
14.
Masina H, Lin I, Chien L
. The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini. Int J Public Health. 2022; 67:1605225.
PMC: 9643149.
DOI: 10.3389/ijph.2022.1605225.
View
15.
ODonnell M, Daftary A, Frick M, Hirsch-Moverman Y, Amico K, Senthilingam M
. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2016; 20(4):430-4.
PMC: 4863995.
DOI: 10.5588/ijtld.15.0360.
View
16.
Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L
. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208.
PMC: 7254481.
DOI: 10.1016/j.jbi.2019.103208.
View
17.
Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M
. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. Int J Tuberc Lung Dis. 2014; 18(4):441-8.
DOI: 10.5588/ijtld.13.0742.
View
18.
Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh T
. TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant.... Trials. 2022; 23(1):484.
PMC: 9190445.
DOI: 10.1186/s13063-022-06331-8.
View
19.
Guest G, Namey E, Chen M
. A simple method to assess and report thematic saturation in qualitative research. PLoS One. 2020; 15(5):e0232076.
PMC: 7200005.
DOI: 10.1371/journal.pone.0232076.
View
20.
Udwadia Z, Furin J
. Quality of drug-resistant tuberculosis care: Gaps and solutions. J Clin Tuberc Other Mycobact Dis. 2019; 16:100101.
PMC: 6830144.
DOI: 10.1016/j.jctube.2019.100101.
View